EMA recommends authorization of Moderna combination COVID/flu vaccine
Source: SeekingAlpha
2026-02-27 09:27:55 ET
More on Moderna
- Moderna, Inc. (MRNA) Q4 2025 Earnings Call Transcript
- Moderna, Inc. 2025 Q4 - Results - Earnings Call Presentation
- Moderna: FDA RTF Derails mRNA-1010 And Reignites The Sell Case
- CDC advisory meeting in March to focus on COVID-19 vaccine injuries, long COVID
- CDC vaccine panel to meet in March after delay
Read the full article on Seeking Alpha
For further details see:
EMA recommends authorization of Moderna combination COVID/flu vaccine
Moderna Inc.
NASDAQ: MRNA
MRNA Trading
-6.53% G/L:
$53.35 Last:
2,043,827 Volume:
$54.75 Open:
MRNA Latest News
MRNA Stock Data
$16,877,354,918
348,095,445
0.39%
298
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
